לטרוזול טבע ®

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

LETROZOLE 2.5 MG

제공처:

TEVA PHARMACEUTICAL INDUST.LTD

ATC 코드:

L02BG04

약제 형태:

TABLETS

관리 경로:

PER OS

Manufactured by:

TEVA PHARMACEUTICAL INDUSTRIES LTD

치료 그룹:

LETROZOLE

치료 징후:

Letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: Letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

승인 날짜:

2010-01-01